GSK PLC (GSK) reports robust growth in specialty medicines and vaccines, with a focus on advancing key assets in oncology and respiratory diseases.
Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results